Lv6
2450 积分 2021-12-29 加入
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial
6天前
已完结
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial
7个月前
已完结
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
7个月前
已完结
Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations
8个月前
已完结
Correction for Sim et al., High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
10个月前
已完结
Landscape of somatic alterations in large-scale solid tumors from an Asian population
10个月前
已完结
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
10个月前
已完结
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
10个月前
已完结
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma
1年前
已完结
Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
1年前
已完结
皖公网安备34019202002308
